top of page
< Back

QuanMol Tech.

Founded Year:

2022

Category:

AI in Drug Discovery

Stage:

Seed+

Website:

About

Committed to transforming the drug development domain, QuanMol's platform equips chemists with the tools to detect less-than-ideal substrates, offering them pragmatic solutions grounded in robust reasoning. Mimicking the process of engaging with experienced peers, QuanMol seamlessly connects theoretical chemistry with real-world application. Harnessing tools such as the Thinker module, the company promotes intuitive interfaces while integrating advanced multi-modeling interaction analytics, solidifying its leadership in drug refinement and molecular studies.

What Founders say:

Xingyu Shen, Ph.D.
Xingyu Shen, Ph.D.
CEO

"Joining the H7 Accelerator program, we aspire to forge meaningful partnerships with customers and investors while showcasing our cutting-edge product to the wider community."

bottom of page